SRI to expand current preclinical molecular imaging capabilities with MILabs VECTor+ system

MILabs is pleased to announce that Sunnybrook Research Institute (SRI), the research arm of the Sunnybrook Health Sciences Centre, located in Toronto, Canada will install a MILabs VECTor⁺ system to expand their current preclinical molecular imaging capabilities. The VECTor⁺ is able to deliver high resolution, sensitivity and scanning speed for SPECT, PET and true simultaneous SPECT/PET experiments contributing to outstanding imaging and quantification results for brain, cardiac, cancer and musculoskeletal applications.

The MILabs VECTor⁺ will be installed in Sunnybrook’s new Biomedical Imaging Research Suite, opened in 2011, which is housed within the Centre for Research in Image‐Guided Therapeutics (CeRIGT). This is a unique $160‐million centre of research and excellence that is bringing medicine from the lab to patients. CeRIGT teams develop and test new ways to diagnose and treat cancer, heart disease, musculoskeletal disorders, immune deficiencies, stroke, dementia and other neurological conditions. The work being done at the centre covers the entire span of biomedical research – from basic research to clinical trials.

Utilization of the VECTor⁺ will be led by Greg Stanisz, PhD a senior scientist in physical sciences. The system will add to the breadth of equipment and multidisciplinary focus of the biomedical imaging research suite and contribute to the integration of preclinical and clinical modalities at CeRIGT.

MILabs is very excited to have the opportunity to work with such a prestigious institution and team of investigators at the Sunnybrook Research Institute and for the VECTor⁺ system to play such a significant role in supporting the development and advancement of biomedical research in Toronto.

Source: http://www.milabs.com/